Search

Spire Healthcare Group PLC

Cerrado

210 1.94

Resumen

Variación precio

24h

Actual

Mínimo

205

Máximo

210

Métricas clave

By Trading Economics

Ingresos

6.5M

Ventas

797M

P/B

Media del Sector

42.196

59.156

BPA

0.041

Rentabilidad por dividendo

1.1

Margen de beneficios

0.816

Empleados

15,703

EBITDA

109M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+33.5% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.10%

2.55%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

849M

Apertura anterior

208.06

Cierre anterior

210

Spire Healthcare Group PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 ene 2026, 23:07 UTC

Ganancias

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 ene 2026, 21:27 UTC

Ganancias

Texas Instruments 4Q Sales Rise, Profit Falls

27 ene 2026, 23:55 UTC

Charlas de Mercado

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 ene 2026, 23:47 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 ene 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 ene 2026, 23:39 UTC

Charlas de Mercado

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 ene 2026, 23:20 UTC

Ganancias

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 ene 2026, 23:20 UTC

Ganancias

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 ene 2026, 23:19 UTC

Ganancias

SK Innovation Posts Net Loss for Second Consecutive Year

27 ene 2026, 23:19 UTC

Ganancias

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 ene 2026, 23:18 UTC

Ganancias

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 ene 2026, 23:18 UTC

Ganancias

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 ene 2026, 23:11 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

27 ene 2026, 23:11 UTC

Charlas de Mercado

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 ene 2026, 23:07 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 ene 2026, 22:17 UTC

Charlas de Mercado

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 ene 2026, 22:06 UTC

Ganancias

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 ene 2026, 21:51 UTC

Ganancias

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

27 ene 2026, 21:43 UTC

Ganancias

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 ene 2026, 21:41 UTC

Ganancias

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 ene 2026, 21:38 UTC

Ganancias

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 ene 2026, 21:32 UTC

Ganancias

Ampol: Modest Profit From F&I International in 2025

27 ene 2026, 21:32 UTC

Ganancias

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 ene 2026, 21:31 UTC

Ganancias

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 ene 2026, 21:31 UTC

Ganancias

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 ene 2026, 21:30 UTC

Ganancias

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 ene 2026, 21:29 UTC

Ganancias

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 ene 2026, 21:29 UTC

Ganancias

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 ene 2026, 21:28 UTC

Ganancias

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Spire Healthcare Group PLC previsión

Precio Objetivo

By TipRanks

33.5% repunte

Estimación a 12 Meses

Media 275 GBX  33.5%

Máximo 275 GBX

Mínimo 275 GBX

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Spire Healthcare Group PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Spire Healthcare Group PLC

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers in-patient, daycase, and out-patient care services through hospitals and clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
help-icon Live chat